SEC Form 3 · accession 0001144204-18-051408
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fosun International Ltd
10% Owner
Period of report
May 4, 2018
Accepted (ET)
Sep 28, 2018 · 10:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | holding | — | — | — | 16,438,356 | I | by Ambient Impact (HK) Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ambient Impact (HK) Limited is an indirect wholly-owned subsidiary of the Reporting Person.